Subject of the day
BRKR
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.
FY 2011–2025 · 15 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $3.44B | +18.7% | |
| Gross profit | $1.51B | +19.4% | |
| Operating income | $68.20M | +7.2% | |
| Net income | $427.20M | +25.6% | |
| Cash from ops | $134.10M | -6.5% |
$57.93
▼ -1.34 (-2.3%)
| 52w hi | $64.34 |
|---|---|
| 52w lo | $29.21 |
| Vol | 1.73M |
| As of | Aug 13 |
Our score +0.18
| Short | +0.20 |
|---|---|
| Medium | +0.32 |
| Long | -0.12 |
computed 2026-08-12
Bruker Corporation
Healthcare · Medical Devices
| Market cap | $8.83B |
|---|---|
| Enterprise value | $10.76B |
| Trailing P/E | — |
| Forward P/E | 24.07x |
| EV / EBITDA | 19.88x |
| P / S (ttm) | 2.52x |
| Profit margin | -2.0% |
| Return on equity | -3.0% |
| Revenue growth | +5.2% |
| Earnings growth | — |
| Debt / equity | 76.16 |
| Beta vs SPX | 1.20 |
|---|---|
| Corr SPX | 0.36 |
| Annual vol | 53.4% |
| Annual ret | +10.0% |
| Sharpe | 0.19 |
| Max DD | -58.5% |
Window: 504 trading days (504 obs)
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.01 | |
| Sector | +0.12 | |
| Technical | +0.15 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-08-12
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Aug 13 | $59.27 | $59.74 | $57.57 | $57.93 | 1.73M |
| Aug 12 | $57.13 | $59.28 | $56.73 | $59.27 | 2.31M |
| Aug 11 | $56.06 | $57.50 | $55.50 | $57.02 | 1.77M |
| Aug 10 | $53.14 | $56.56 | $53.14 | $56.32 | 2.50M |
| Aug 7 | $52.02 | $53.47 | $51.20 | $53.41 | 2.11M |